Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
ConclusionAnti-GD2-directed immunotherapy represents an additional therapeutic option in high-risk metastasized RB. Moreover, CD276 is another target of interest.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Austria Health | Brain | Cancer | Cancer & Oncology | Eye Cancers | Germany Health | Immunotherapy | Neuroblastoma | Neurology | Retinoblastoma | Stem Cell Therapy | Stem Cells | Toxicology | Transplants